Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aurobindo Pharma declares 'hidden' income
Times of India, India
Sunday, February 12, 2012 - 11:25am
tags:
Aurobindo
Amgen To Near $100, Outperforming Pfizer
Seeking Alpha
Sunday, February 12, 2012 - 11:23am
tags:
Pfizer, Amgen
Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution
Bradenton Herald, FL
Saturday, February 11, 2012 - 1:51pm
tags:
Xopenex, Sunovion, Mylan
Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
Bradenton Herald, FL
Saturday, February 11, 2012 - 12:54pm
tags:
BioSante
Biomarin Pharm Shares Downgraded by Zacks Investment Research to “Underperform” (BMRN)
Web Inquirer, UK
Saturday, February 11, 2012 - 12:52pm
tags:
Biomarin
Dava Pharmaceuticals Pays $11 Million to Settle False Claims Act Allegations
Industry Week
Saturday, February 11, 2012 - 12:50pm
tags:
Dava Pharmaceuticals
How a NASA Discovery Could Launch a Coup in the Pharmaceutical Industry
Wall St Daily
Saturday, February 11, 2012 - 12:48pm
tags:
drug delivery
Vernalis shares rise 28% after US cold medicine deal
Guardian, UK
Saturday, February 11, 2012 - 12:46pm
tags:
Vernalis, Tris Pharma
GSK, Takeda say nay to in-house diagnostics units
FiercePharma
Saturday, February 11, 2012 - 12:42pm
tags:
GSK, Takeda
KV Pharmaceutical’s Q4 loss more than 7 times revenue
bizjournals.com
Saturday, February 11, 2012 - 12:37pm
tags:
KV Pharmaceutical
Watson Settles Patent Dispute
Yahoo/Zacks
Saturday, February 11, 2012 - 12:36pm
tags:
Watson Pharmaceuticals
Abbott Labs Offers Long, Solid Dividend History
Investors.com
Saturday, February 11, 2012 - 12:35pm
tags:
Abbott Laboratories
Incyte in Neutral Lane
Yahoo/Zacks
Saturday, February 11, 2012 - 12:33pm
tags:
Incyte
Big Pharma: 3 To Avoid, 1 To Buy
Seeking Alpha
Saturday, February 11, 2012 - 12:17pm
tags:
Abbott Laboratories, Eli Lilly, Merck, Bristol-Myers Squibb
1 Biotech to Buy Post-Plunge
Motley Fool
Saturday, February 11, 2012 - 11:56am
tags:
Astex
Why It's Time To Sell These 4 Healthcare Stocks
Seeking Alpha
Saturday, February 11, 2012 - 11:51am
tags:
Merck, Pfizer, Abbott Laboratories, Boston Scientific
The Truly Staggering Cost Of Inventing New Drugs
Forbes
Saturday, February 11, 2012 - 11:50am
tags:
R&D
Sanofi Beats Earnings Estimates
Yahoo/Zacks
Saturday, February 11, 2012 - 11:49am
tags:
Sanofi
The Skinny on Upcoming Obesity FDA Meetings
Motley Fool
Saturday, February 11, 2012 - 11:44am
tags:
Vivus, Qnexa, Arena Pharmaceuticals, lorcaserin, pixantrone, Cell Therapeutics, obesity, weight loss
Halozyme Therapeutics
Investors Business Daily
Saturday, February 11, 2012 - 11:42am
tags:
Halozyme

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.